Opioid abuse is a serious problem in Maine with a societal cost of 1.4 billion dollars. Buprenorphine has been used as an office based treatment for addiction management. In Maine there is a provider shortage for substance abuse and a large need in the community for treatment. In fact, there were 272 deaths in 2015 attributed to overdose. It is important that once patients begin treatment they remain in treatment without relapse. At EMMC Center for Family Medicine we explored the risks for relapse from the provider perspective, patient perspective and retrospective chart analysis in order to guide future interventions at this treatment program.https://scholarworks.uvm.edu/fmclerk/1178/thumbnail.jp
